Anti‐Ce in haemolytic disease of the foetus and newborn
Anti-Ce titre monitoring beyond 28 weeks gestation and specialist foetal team involvement early in pregnancy should be considered despite current BSH Guidelines, along with extended neonatal monitoring.
Authors
- Joan Fitzgerald (ORCID: https://orcid.org/0000-0002-2110-6969)
- Catherine Flynn (ORCID: https://orcid.org/0000-0002-9740-6757)
- Jan Miletín (ORCID: https://orcid.org/0000-0003-0489-6054)
- Edel Scally
- Carmen Regan (ORCID: https://orcid.org/0000-0001-8438-7000)
- Fergus Guilfoyle
- Richard B. OʼGrady
Institutions
- Coombe Women & Infants University Hospital (IE)
- National Maternity Hospital (IE)
- Irish Blood Transfusion Service (IE)
- St. James's Hospital (IE)
Publication Details
- Journal
- Transfusion Medicine
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1111/tme.13134
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00